Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans

Journal of Neuroendocrinology

Volumn 18, Issue 2, 2006, Pages 115-121

  Heindl, Silke ^a   Holzschneider, J ^a   Hinz, A ^a   Sayk, F ^a   Fehm, H L ^a   Dodt, C ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Aldosterone; Autonomic nervous system; Baroreflex; Heart rate variability; Muscle sympathetic nerve activity

Indexed keywords

ADRENALIN; ALDOSTERONE; HYDROCORTISONE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; PLACEBO; POTASSIUM ION; RENIN; SODIUM ION; VASOPRESSIN;

ADRENERGIC SYSTEM; ADULT; APNEA; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG POTENTIATION; DRUG RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERONEUS NERVE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VAGUS TONE;

ADOLESCENT; ADRENERGIC FIBERS; ADULT; ALDOSTERONE; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; MALE; MUSCLE, SKELETAL; NITROPRUSSIDE; PHENYLEPHRINE; PRESSORECEPTORS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; SYMPATHOMIMETICS;

EID: 33645866767     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2005.01392.x     Document Type: Article

References (50)

1. White PC. Aldosterone: Direct effects on and production by the heart. J Clin Endocrinol Metab 2003; 88: 2376-2383.
2. Farquharson CA, Struthers AD. Aldosterone induces acute endothelial dysfunction in vivo in humans: Evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) 2002; 103: 425-431.
3. Struthers AD. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. J Card Fail 1996; 2: 47-54.
4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Invest N Engl J Med 1999; 341: 709-717.
5. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves Volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 2001; 281: H2241-H2251.
6. Wang H, Huang BS, Leenen FH. Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 2003; 285: H2516-H2523.
7. Huang BS, Wang H, Leenen FH. Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats. Am J Physiol Heart Circ Physiol 2005; 288: H517-H524.
8. Barr CS, Lang CC, Hanson J, Arnott M, Kennedy N, Struthers AD. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995; 76: 1259-1265.
9. MacFadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997; 35: 30-34.
10. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003; 41: 574-581.
11. Izzo JLJ, Horwitz D, Lawton WJ, Keiser HR. Fludrocortisone suppression of sympathetic nervous activity. Clin Pharmacol Ther 1983; 33: 102-106.
12. Mion D, Rea RF, Anderson EA, Kah D, Sinkey C, Mark AL. Effects of fludrocortisone on sympathetic nerve activity in humans. Hypertension 1994; 23: 123-130.
13. Wang M, McClaim JM, Zucker IH. Aldosterone reduces baroreceptor discharge in the dog. Hypertension 1992; 19: 270-277.
14. Yee KM, Struthers AD. Aldosterone blunts the baroreflex response in man. Clin Sci 1998; 95: 687-692.
15. Schmidt BMW, Montealegre A, Janson CP, Martin N, Stein-Kemmesies C, Scherhag A, Feuring M, Christ M, Wehling M. Short term cardiovascular effects of aldosterone in healthy male volunteers. J Clin Endocrinol Metab 1999; 84: 3528-3533.
16. Fletcher J, Buch AN, Routledge HC, Chowdhary S, Coote JH, Townend JN. Acute aldosterone antagonism improves cardiac vagal control in humans. J Am Coll Cardiol 2004; 43: 1270-1275.
17. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol Lond 1992; 453: 45-58.
18. Hirshoren N, Tzoran I, Makrienko I, Edoute Y, Plawner MM, Itskovitz-Eldor J, Jacob G. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab 2002; 87: 1569-1575.
19. Dodt C, Keyser B, Mölle M, Fehm HL, Elam M. Acute suppression of muscle sympathetic nerve activity by hydrocortisone in humans. Hypertension 2000; 35: 758-763.
20. Heindl S, Dodt C, Krahwinkel M, Hasenfuß G, Andreas S. Effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure. Heart 2001; 85: 185-190.
21. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 1995; 92: 3206-3211.
22. Eriksson BM, Persson BA. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 1982; 228: 143-154.
23. Kleiger RE, Stein PK, Bosner MS, Rottmann JN. Time-Domain Measurements of Heart Rate Variability. Armonk, NY: Futura, 1995: 33-46.
24. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-1065.
25. Wallin BG. Relationship between sympathetic nerve traffic and plasma concentrations of noradrenaline in man. Pharmacol Toxicol 1988;S1: 9-11.
26. Wallin BG, Fagius J. Peripheral sympathetic neural activity in conscious humans. Ann Rev Physiol 1988; 50: 565-576.
27. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates wih muscle sympathetic activity in humans. J Physiol 1996; 491: 881-887.
28. Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton GE, Floras JS, Parker JD. Nonselective versus selective beta-adrenergic receptor blockade in congestive heart failure. Differential effects on sympathetic activity. Circulation 2001; 104: 2194-2199.
29. Hayano J, Sakakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, Yokoyama K, Watanabe Y, Takata K. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991; 67: 199-204.
30. Goldberger JJ, Challapalli S, Tung R, Parker MA, Kadish AH. Relationship of heart rate variability to parasympathetic effect. Circulation 2001; 103: 1977-1983.
31. Eckberg DL. Sympathovagal balance. A critical appraisal. Circulation 1997; 96: 3224-3232.
32. Gómez-Sánchez EP. Central hypertensive effects of aldosterone. Front Neuroendocrinol 1997; 18: 440-462.
33. Yee KM, Pringle SD, Struthers AD. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol 2001; 37: 1800-1807.
34. Losel R, Schultz A, Boldyreff B, Wehling M. Rapid effects of aldosterone on vascular cells: Clinical implications. Steroids 2004; 69: 575-578.
35. Sudhir K, Jennings G, Esler MD, Korner PI, Blombery PA, Lambert GW, Scoggins B, Whitworth JA. Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 1989; 13: 416-421.
36. Hauck RW, Harth M, Schulz C, Prauer H, Bohm M, Schomig A. Effects of beta 2-agonist- and dexamethasone-treatment on relaxation and regulation of beta-adrenoceptors in human bronchi and lung tissue. Br J Pharmacol 1997; 121: 1523-1530.
37. Weber MA, Purdy RE. Catecholamine mediated constrictor effects of aldosterone on vascular smooth muscle. Life Sci 1982; 30: 2009-2017.
38. Bucher B, Ouedraogo S, Tschopl M, Paya D, Stoclet JC. Role of the 1-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol 1992; 107: 976-982.
39. Choate JK, Paterson DJ. Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea pig atria. J Auton Nerv Syst 1999; 75: 101-108.
40. Sears CE, Choate JK, Paterson DJ. NO-cGMP pathway accentuates the decrease in heart rate caused by cardiac vagal nerve stimulation. J Appl Physiol 1999; 86: 510-516.
41. Chun TY, Bloem LJ, Pratt JH. Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes. Endocrinology 2003; 144: 1712-1717.
42. Best JB, Bett JHN, Coghlan JP, Cran EJ. Circulating angiotensin-II and aldosterone levels during dietary sodium restriciton. The Lancet 1971; 1: 1353-1354.
43. Mason PA, Fraser R, Morton JJ, Semple PF, Wilson A. The effect of sodium deprivation and of angiotensin II infusion on the peripheral plasma concentrations of 18-hydroxycorticosterone, aldosterone and other corticosteroids in man. J Steroid Biochem 1977; 8: 799-804.
44. Cain JP, Tuck ML, Williams GH, Dluhy RG, H. RS. The regulation of aldosterone secretion in primary aldosteronism. Am J Med 1972; 53: 627-637.
45. Nicholls MG, Espiner EA, Donald RA, Hughes H. Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med 1974; 47: 301-315.
46. Coghlan JP, Doyle AE, Jerums G, Scoggins BA. The effects of sodium loading and deprivation on plasma renin and plasma and urinary aldosterone in hypertension. Clin Sci 1972; 42: 15-23.
47. Verrey F. Early aldosterone action. toward filling the gap between transcription and transport. Am J Physiol 1999; 277: F319-F327.
48. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones. a focus on rapid, nongenomic effects. Pharmacol Rev 2000; 52: 513-555.
49. Wehling M, Spes C, Win N, Janson C, Schmidt BMW, Theisen K, Christ M. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998; 83: 3517-3522.
50. Schmidt BM, Georgens AC, Martin N, Tillmann HC, Feuring M, Christ M, Wehling M. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J Clin Endocrinol Metab 2001; 86: 761-767.